Cell death & disease. 2018 Apr 1;9(4):432. doi: 10.1038/s41419-018-0409-0 Q19.62025
BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression
BPIFB1(LPLUNC1)通过抑制VTN表达抑制鼻咽癌放射抵抗性 翻译改进
作者单位 +展开
作者单位
DOI: 10.1038/s41419-018-0409-0 PMID: 29568064
摘要 Ai翻译
相关内容
-
Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice
小鼠鼻腔和口腔中BPIFA1(SPLUNC1)和BPIFB1(LPLUNC1)的差异定位
Maslinda Musa et al.
Cell and tissue research. 2012 Dec;350(3):455-64.
-
HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis
受LPLUNC1调控的HYOU1在鼻咽癌中高表达且预示不良预后
Yujuan Zhou et al.
Journal of Cancer. 2016 Jan 12;7(4):367-76.
-
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis
LPLUNC1通过PHB1-p53/c-Myc轴降低鼻咽癌细胞的糖酵解作用
Linda Oyang et al.
Cancer science. 2023 Mar;114(3):870-884.
-
MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B
微小核糖核酸-324-3P通过直接靶向WNT2B调节鼻咽癌放射抵抗性
Guo Li et al.
European journal of cancer (Oxford, England : 1990). 2013 Jul;49(11):2596-607.
-
Twist1 promotes radioresistance in nasopharyngeal carcinoma
TWIST1促进鼻咽癌放射抵抗性作用及机制研究
Linli Zhang et al.
Oncotarget. 2016 Dec 6;7(49):81332-81340.
-
ATF5 involved in radioresistance in nasopharyngeal carcinoma by promoting epithelial-to-mesenchymal phenotype transition
ATF5通过促进上皮间质转化促进鼻咽癌放射抵抗性的作用及机制研究
Yu Shuai et al.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2020 Oct;277(10):2869-2879.
-
LACTB2 renders radioresistance by activating PINK1/Parkin-dependent mitophagy in nasopharyngeal carcinoma
LACTB2通过激活PINK1/Parkin依赖的自噬在鼻咽癌中产生放射抵抗性
Qianping Chen et al.
Cancer letters. 2021 Oct 10:518:127-139.
-
SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
SATB1通过ATM/Chk2/p53途径诱导鼻咽癌放射抵抗性
Xin Nie et al.
Cancer medicine. 2019 Apr;8(4):1779-1792.